The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

The affair: Maybe you've considered it. Maybe you're in it. Today's women are acting on the urge, more than ever before, a new survey reveals. One in five married women has had a fling -- the ...

Every time you visit the grocery store, your brain is absorbing countless food-packaging cues. Those cues influence your choices more than you think.

How To Work With Your Medical Team To Improve Your Liver Health ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...